Sequence-based Analysis of Parasite Diversity and Host Interactions

Information

  • Research Project
  • 8831596
  • ApplicationId
    8831596
  • Core Project Number
    U19AI110819
  • Full Project Number
    5U19AI110819-02
  • Serial Number
    110819
  • FOA Number
    RFA-AI-13-009
  • Sub Project Id
    6910
  • Project Start Date
    -
  • Project End Date
    -
  • Program Officer Name
  • Budget Start Date
    4/1/2015 - 9 years ago
  • Budget End Date
    3/31/2016 - 8 years ago
  • Fiscal Year
    2015
  • Support Year
    02
  • Suffix
  • Award Notice Date
    3/10/2015 - 9 years ago

Sequence-based Analysis of Parasite Diversity and Host Interactions

Human parasites cause some of the most important infectious diseases worldwide (e.g. malaria), and infect millions of individuals each year within the US (e.g. toxoplasma). Despite the availability of several reference sequences for parasite genomes, we have a very limited understanding of the mechanisms by which parasites infect and persist within their human hosts. This project will exploit current high-throughput sequencing technologies and bioinformatics techniques to provide novel insights to parasitic infectious diseases. Our broad objectives are to understand pathogen diversity, evolution, and their interactions with the human host and associated microbiota. These objectives are addressed through three specific aims, applied to two apicomplexan species of major concern in the US {Toxoplasma gondii) and worldwide {Plasmodium falciparum). Particular emphasis is given to the study of host-parasite interactions, through the sequencing of DNA and RNA from both the parasites and their human hosts. Specific Aim 1 will apply sequence-based analysis of natural and mutant T. gondii strains to determine the worldwide genomic complexity for this species, and permit predictions of host and parasite genes that are involved with specific infection and replication phenotypes. Specific Aim 2 will apply sequence-based analysis of host-parasite interactions during experimental and natural P. falciparum infections of humans, to identify the genomic and transcriptomic basis of immune profiles that are associated with protection from the symptoms of malaria. Specific Aim 3 will characterize the composition of bacterial and eukaryotic species in the gut microbiome during the course of infections with P. falciparum to determine the reciprocal effects on microbiome composition and disease progression. Each of the specific aims employs innovative experimental designs and technology development, and is most appropriate for a large-scale program that can generate and process extensive volumes of sequence data. The project addresses important problems that apply to the specific species under study, and to the larger field of parasitic infectious disease. By achieving the objectives of this project, we will provide a model for how future projects could be accomplished for many other pathogens of interest.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    U19
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
    149227
  • Indirect Cost Amount
    131320
  • Total Cost
  • Sub Project Total Cost
    209077
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIAID:209077\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZAI1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    J. CRAIG VENTER INSTITUTE, INC.
  • Organization Department
  • Organization DUNS
    076364392
  • Organization City
    ROCKVILLE
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    208503343
  • Organization District
    UNITED STATES